Clinical Trial Update: A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy [Phase 3]

View source ↗

Summary

This is a Phase 3 trial comparing epoetin alfa plus standard supportive care to standard supportive care alone in anemic patients with metastatic breast cancer …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• EPOETIN ALFA (EPOETIN ALFA)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Breast Cancer, Neoplasm Metastasis | Phase 3 | Status: COMPLETED | Results posted: 2016-03-24